Ascentage Pharma’s Core Drug Candidate HQP1351 Granted Orphan Drug Designation by the US FDA for the Treatment of Patients with Chronic Myeloid Leukemia Life Science
Healthcare Roundup – FDA OKs subcutaneous version of J&J’s Darzalex, European advisory group backs expanded label of Gilead’s Harvoni Life Science
Atreca, BeiGene, and IGM Biosciences Agree to Collaborate on Novel Antibody Treatment for COVID-19 Life Science
Bayer and OrigiMed reached a partnership to develop a next generation sequencing (NGS) based companion diagnostic-in vitro diagnostic (CDx-IVD) product in China for Larotrectinib, for NTRK gene fusion detection Life Science
Healthcare Roundup – AstraZeneca teams up with Oxford U. on COVID-19 vaccine, Molina to buy Magellan Life Science
Healthcare Roundup – Gilead Sciences Q1 2020 Earnings Preview, FDA OKs expanded use of Glaxo’s Zejula Life Science
Healthcare Roundup – Roche’s entrectinib OK’d in Canada, Sarepta up 5% premarket on COVID-19 plan Life Science
Healthcare Roundup —— Sorrento Therapeutics in deal for up to $250M, Moderna submits IND application for Phase 2 COVID-19 study Life Science
Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate’s International, Phase III Clinical Study Life Science
Hua Medicine Announces Positive Results of the Combination Study of Dorzagliatin with Empagliflozin (a SGLT-2 inhibitor) Life Science
Healthcare Roundup – Translate Bio jumps 21% on bullish comments from vaccine partner Sanofi, Gilead’s remdesivir trial ahead of schedule Life Science
Hansoh Pharma and NiKang Therapeutics Enter into a Development and Commercialization Partnership for a Novel Treatment for Anti-Viral Diseases in China Life Science
